Loews Corp Aerie Pharmaceuticals Inc Transaction History

Loews Corp

  • $11.8 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 12, 2020
SELL
$11.84 - $25.52 $151,552 - $326,656
-12,800 Closed
0 $0
Q4 2019

Feb 13, 2020
SELL
$17.72 - $25.1 $139,899 - $198,164
-7,895 Reduced 38.15%
12,800 $309,000
Q3 2019

Nov 07, 2019
BUY
$18.41 - $28.0 $380,994 - $579,460
20,695 New
20,695 $398,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Loews Corp Portfolio

Follow Loews Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loews Corp, based on Form 13F filings with the SEC.

News

Stay updated on Loews Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email